Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Tocotrienols: inflammation and cancer.

Nesaretnam K, Meganathan P.

Ann N Y Acad Sci. 2011 Jul;1229:18-22. doi: 10.1111/j.1749-6632.2011.06088.x. Review.

PMID:
21793834
2.

Multifaceted link between cancer and inflammation.

Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, Tergaonkar V.

Biosci Rep. 2012 Feb;32(1):1-15. doi: 10.1042/BSR20100136. Review.

PMID:
21981137
3.

Targeting the inflammatory pathways to enhance chemotherapy of cancer.

Zhu Z, Zhong S, Shen Z.

Cancer Biol Ther. 2011 Jul 15;12(2):95-105. Review.

PMID:
21623164
4.

Why cancer and inflammation?

Rakoff-Nahoum S.

Yale J Biol Med. 2006 Dec;79(3-4):123-30. Review.

5.

Inflammation and cancer: when NF-kappaB amalgamates the perilous partnership.

Dobrovolskaia MA, Kozlov SV.

Curr Cancer Drug Targets. 2005 Aug;5(5):325-44. Review.

PMID:
16101381
6.

Cancer chemopreventive activity of maslinic acid: suppression of COX-2 expression and inhibition of NF-κB and AP-1 activation in Raji cells.

Hsum YW, Yew WT, Hong PL, Soo KK, Hoon LS, Chieng YC, Mooi LY.

Planta Med. 2011 Jan;77(2):152-7. doi: 10.1055/s-0030-1250203.

PMID:
20669087
7.

NF-kappaB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment.

Bours V, Bonizzi G, Bentires-Alj M, Bureau F, Piette J, Lekeux P, Merville M.

Toxicology. 2000 Nov 16;153(1-3):27-38. Review.

PMID:
11090945
8.
9.
10.

Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.

Wong ET, Tergaonkar V.

Clin Sci (Lond). 2009 Mar;116(6):451-65. doi: 10.1042/CS20080502. Review.

PMID:
19200055
11.

Molecular therapeutic targets in inflammation: cyclooxygenase and NF-kappaB.

Krakauer T.

Curr Drug Targets Inflamm Allergy. 2004 Sep;3(3):317-24. Review.

PMID:
15379601
12.

Prevention of human cancer by modulation of chronic inflammatory processes.

Ohshima H, Tazawa H, Sylla BS, Sawa T.

Mutat Res. 2005 Dec 11;591(1-2):110-22. Review.

PMID:
16083916
13.

Anti-inflammatory plant natural products for cancer therapy.

Aravindaram K, Yang NS.

Planta Med. 2010 Aug;76(11):1103-17. doi: 10.1055/s-0030-1249859. Review.

PMID:
20432202
14.

Cancer related inflammation: the macrophage connection.

Sica A, Allavena P, Mantovani A.

Cancer Lett. 2008 Aug 28;267(2):204-15. doi: 10.1016/j.canlet.2008.03.028. Review.

PMID:
18448242
15.

Multitargeted therapy of cancer by tocotrienols.

Nesaretnam K.

Cancer Lett. 2008 Oct 8;269(2):388-95. doi: 10.1016/j.canlet.2008.03.063. Review.

PMID:
18504069
16.

Guggulsterone (GS) inhibits smokeless tobacco and nicotine-induced NF-κB and STAT3 pathways in head and neck cancer cells.

Macha MA, Matta A, Chauhan SS, Siu KW, Ralhan R.

Carcinogenesis. 2011 Mar;32(3):368-80. doi: 10.1093/carcin/bgq278.

17.

Anticancer activity of a cyclooxygenase inhibitor, CX9051, in human prostate cancer cells: the roles of NF-kappaB and crosstalk between the extrinsic and intrinsic apoptotic pathways.

Huang CH, Guh JH, Chen GS, Lu PH, Chern JW.

Naunyn Schmiedebergs Arch Pharmacol. 2010 Aug;382(2):159-69. doi: 10.1007/s00210-010-0528-3.

PMID:
20532752
19.

Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling.

Park SK, Sanders BG, Kline K.

Breast Cancer Res Treat. 2010 Nov;124(2):361-75. doi: 10.1007/s10549-010-0786-2.

PMID:
20157774
20.

Roles of inflammation in cancer initiation, progression, and metastasis.

Rajput S, Wilber A.

Front Biosci (Schol Ed). 2010 Jan 1;2:176-83.

PMID:
20036938
Items per page

Supplemental Content

Support Center